Manjusha Gaglani

Also affiliated with Baylor Scott & White Health

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

12.9Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7110a1

Top 1%

11.0DataRank

Top 1%116 citations

Sara Kim, Rebecca Kondor, Catherine M. Smith, Alicia Budd, Sara Y. Tartof +24 more

Papers

Driven by 95 papers — median percentile 72. Top paper: “Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022”.

Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7110a1

Top 1%

11.0DataRank

Top 1%116 citations

Sara Kim, Rebecca Kondor, Catherine M. Smith, Alicia Budd, Sara Y. Tartof +24 more

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023

Clinical Infectious Diseases(2023)10.1093/cid/ciad505

Top 22%

0.902DataRank

Top 22%27 citations

Patrick K. Mitchell, Victoria Lazariu, Manjusha Gaglani, Charlene McEvoy, Nicola P. Klein +41 more

Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016

Influenza and Other Respiratory Viruses(2020)10.1111/irv.12741

Top 35%

0.565DataRank

Top 35%9 citations

Mary Patricia Nowalk, Theresa M. Sax, Joe Suyama, Emily Bobyock, Charles R. Rinaldo +8 more

Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf185

Top 44%

0.419DataRank

Top 44%7 citations

Elizabeth Harker, Seana Cleary, Yuwei Zhu, Carlos G. Grijalva, James D. Chappell +42 more

Reducing Antibiotic Use in Ambulatory Care Through Influenza Vaccination

Clinical Infectious Diseases(2020)10.1093/cid/ciaa464

N/A

0DataRank · unranked

16 citations

Alicia M. Fry, Lauri A. Hicks, Katherine E. Fleming-Dutra, Brendan Flannery, Jill M. Ferdinands +11 more

Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa576

N/A

0DataRank · unranked

16 citations

Sara Kim, Michael L. Jackson, Lisa A. Jackson, Edward A. Belongia, Jennifer P. King +9 more

Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018–2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa772

N/A

0DataRank · unranked

24 citations

Manjusha Gaglani, Shekhar Ghamande, Emily T. Martin, Donald B. Middleton, Arnold S. Monto +52 more

Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults—United States, 2015–2017

Clinical Infectious Diseases(2020)10.1093/cid/ciaa160

N/A

0DataRank · unranked

36 citations

Lauren Beacham, Emily T. Martin, H. Keipp Talbot, Arnold S. Monto, Manjusha Gaglani +9 more

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017

Clinical Infectious Diseases(2020)10.1093/cid/ciaa102

N/A

0DataRank · unranked

34 citations

Anupama Vasudevan, Chandni Raiyani, Kempapura Murthy, Wencong Chen, Michael Reis +13 more

Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016–2017 and 2017–2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa685

N/A

0DataRank · unranked

34 citations

Caroline Cheng, Joshua G. Petrie, Elif Alyanak, Manjusha Gaglani, Donald B. Middleton +40 more

Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018

Clinical Infectious Diseases(2020)10.1093/cid/ciaa706

N/A

0DataRank · unranked

27 citations

Brendan Flannery, Ivo Foppa, Jessie R. Chung, Mary Patricia Nowalk, Richard K. Zimmerman +9 more

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015–16 to 2018–19

Vaccine(2020)10.1016/j.vaccine.2020.08.011

N/A

0DataRank · unranked

24 citations

Won Suk Choi, Mary Patricia Nowalk, Richard K. Zimmerman, Arnold S. Monto, Emily T. Martin +12 more

Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1023

N/A

0DataRank · unranked

5 citations

Jennifer K. Meece, John V. Williams, Emily T. Martin, Manjusha Gaglani, Michael L. Jackson +23 more

Clinical symptoms among ambulatory patients tested for SARS-CoV-2

medRxiv(2020)10.1101/2020.10.20.20213272

N/A

0DataRank · unranked

1 citations

Sara Kim, Michael L. Jackson, Lisa A. Jackson, Edward A. Belongia, Jennifer P. King +9 more

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7038e1

N/A

0DataRank · unranked

455 citations

Mark W. Tenforde, Jillian P. Rhoads, Manjusha Gaglani, Adit A. Ginde, David J. Douin +94 more

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7034e2

N/A

0DataRank · unranked

246 citations

Wesley H. Self, Eric A. Naioti, Adit A. Ginde, David J. Douin, Samantha M. Olson +95 more

Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015–2016 to 2018–2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network

Clinical Infectious Diseases(2021)10.1093/cid/ciab045

N/A

0DataRank · unranked

59 citations

Manjusha Gaglani, Emily T. Martin, Arnold S. Monto, Donald B. Middleton, Fernanda P. Silveira +4 more

Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm705152a2

N/A

0DataRank · unranked

46 citations

Patrick Rivers, Young M. Yoo, Lauren Grant, James Hollister, Krystal S. Jovel +29 more

Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators

Clinical Infectious Diseases(2021)10.1093/cid/ciab123

N/A

0DataRank · unranked

33 citations

Emily T. Martin, Manjusha Gaglani, Donald B. Middleton, Shekhar Ghamande, Fernanda P. Silveira +48 more

Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab619

N/A

0DataRank · unranked

23 citations

Eric A. Naioti, Wesley H. Self, Adit A. Ginde, David J. Douin, H. Keipp Talbot +94 more

Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011–2012 through 2018–2019

Vaccine(2021)10.1016/j.vaccine.2021.01.065

N/A

0DataRank · unranked

15 citations

Jessie R. Chung, Sara Kim, Michael L. Jackson, Lisa A. Jackson, Edward A. Belongia +13 more

Role of Age in the Spread of Influenza, 2011–2019: Data From the US Influenza Vaccine Effectiveness Network

American Journal of Epidemiology(2021)10.1093/aje/kwab205

N/A

0DataRank · unranked

7 citations

Brendan Flannery, Ivo Foppa, Manjusha Gaglani, Kempapura Murthy, Michael L. Jackson +11 more

Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015–2016 to 2017–2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Clinical Infectious Diseases(2021)10.1093/cid/ciab654

N/A

0DataRank · unranked

10 citations

Courtney Shaver, Kempapura Murthy, Chandni Raiyani, Heath D. White, Tasnim Lat +12 more

Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study

BMC Public Health(2021)10.1186/s12889-021-10543-z

N/A

0DataRank · unranked

6 citations

Jill M. Ferdinands, Mary Patricia Nowalk, Richard K. Zimmerman, Burney A. Kieke, Manjusha Gaglani +7 more

Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018

Journal of the Pediatric Infectious Diseases Society(2021)10.1093/jpids/piab096

N/A

0DataRank · unranked

6 citations

Angela P. Campbell, Marian G. Michaels, Christopher J. Harrison, Eileen J. Klein, Janet A. Englund +22 more

Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States

Vaccine(2021)10.1016/j.vaccine.2021.05.004

N/A

0DataRank · unranked

5 citations

Brendan Flannery, Sara Kim, Manjusha Gaglani, Chandni Raiyani, Edward A. Belongia +9 more

Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February–May 2021

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab451

N/A

0DataRank · unranked

4 citations

Jessie R. Chung, Edward A. Belongia, Huong Q. McLean, Jennifer P. King, Mary Patricia Nowalk +17 more

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

BMJ(2022)10.1136/bmj-2021-069761

N/A

0DataRank · unranked

684 citations

Mark W. Tenforde, James D. Chappell, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal +54 more

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7112e1

N/A

0DataRank · unranked

184 citations

Wesley H. Self, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot +53 more

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

BMJ(2022)10.1136/bmj-2022-072065

N/A

0DataRank · unranked

115 citations

Jillian P. Rhoads, Diya Surie, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal +35 more

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7104a2

N/A

0DataRank · unranked

100 citations

Manish M. Patel, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot +94 more

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7142a4

N/A

0DataRank · unranked

86 citations

Peter J. Embí, Matthew E. Levy, Manjusha Gaglani, Malini B. DeSilva, Brian E. Dixon +39 more

Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7142a3

N/A

0DataRank · unranked

60 citations

Levi N. Bonnell, Katherine Adams, Manjusha Gaglani, Adit A. Ginde, David J. Douin +94 more

Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season

Clinical Infectious Diseases(2022)10.1093/cid/ciac941

N/A

0DataRank · unranked

60 citations

Brendan Flannery, H. Keipp Talbot, Carlos G. Grijalva, Karen J. Wernli, C. Hallie Phillips +15 more

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac118

N/A

0DataRank · unranked

39 citations

Mark W. Tenforde, Manjusha Gaglani, H. Keipp Talbot, Adit A. Ginde, Tresa McNeal +50 more

Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness

Influenza and Other Respiratory Viruses(2022)10.1111/irv.13023

N/A

0DataRank · unranked

40 citations

Samantha M. Olson, Wesley H. Self, Adit A. Ginde, Nicholas M. Mohr, Manjusha Gaglani +26 more

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022

Influenza and Other Respiratory Viruses(2022)10.1111/irv.13029

N/A

0DataRank · unranked

24 citations

Jessie R. Chung, H. Keipp Talbot, Carlos G. Grijalva, Karen J. Wernli, Erika Kiniry +16 more

Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022

Clinical Infectious Diseases(2022)10.1093/cid/ciac869

N/A

0DataRank · unranked

23 citations

Manish M. Patel, Nathaniel M. Lewis, Katherine Adams, Manjusha Gaglani, Jay S. Steingrub +26 more

Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States

Clinical Infectious Diseases(2022)10.1093/cid/ciac381

N/A

0DataRank · unranked

19 citations

Wesley H. Self, Yuwei Zhu, Eric A. Naioti, Manjusha Gaglani, Adit A. Ginde +56 more

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac698

N/A

0DataRank · unranked

13 citations

Nancy L. Murray, Katherine Adams, Diya Surie, Manjusha Gaglani, Adit A. Ginde +83 more

Vaccine-associated attenuation of subjective severity among outpatients with influenza

Vaccine(2022)10.1016/j.vaccine.2022.06.019

N/A

0DataRank · unranked

6 citations

Sara Kim, Brendan Flannery, Michael Smith, Kayan Dunnigan, Chandni Raiyani +16 more

Burden of medically attended influenza infection and cases averted by vaccination – United States, 2016/17 through 2018/19 influenza seasons

Vaccine(2022)10.1016/j.vaccine.2022.11.011

N/A

0DataRank · unranked

7 citations

C. Hallie Phillips, Stacie Wellwood, Erika Kiniry, Lisa A. Jackson, Emily T. Martin +10 more

Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021

Influenza and Other Respiratory Viruses(2022)10.1111/irv.12973

N/A

0DataRank · unranked

6 citations

Sara Kim, Edward A. Belongia, Huong Q. McLean, Jennifer P. King, Mary Patricia Nowalk +13 more

Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study

medRxiv(2022)10.1101/2022.02.06.22270558

N/A

0DataRank · unranked

32 citations

Mark W. Tenforde, James D. Chappell, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal +55 more

Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States

medRxiv(2022)10.1101/2022.06.09.22276228

N/A

0DataRank · unranked

16 citations

Jillian P. Rhoads, Diya Surie, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal +54 more

Vaccine Effectiveness against COVID-19 among Symptomatic Persons Aged ≥12 Years with Reported Contact with COVID-19 Cases, February – September 2021

medRxiv(2022)10.1101/2021.12.30.21267928

N/A

0DataRank · unranked

1 citations

Sara Kim, Edward A. Belongia, Huong Q. McLean, Jennifer P. King, Mary Patricia Nowalk +13 more

Effectiveness of 2 and 3 mRNA COVID-19 Vaccines Doses against Omicron and Delta-Related Outpatient Illness among Adults, October 2021 – February 2022

medRxiv(2022)10.1101/2022.04.06.22273535

N/A

0DataRank · unranked

1 citations

Jessie R. Chung, H. Keipp Talbot, Carlos G. Grijalva, Karen J. Wernli, Erika Kiniry +16 more

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

MMWR Morbidity and Mortality Weekly Report(2023)10.15585/mmwr.mm7221a3

N/A

0DataRank · unranked

102 citations

Zachary A. Weber, Sarah E. Reese, Amanda B. Payne, Manjusha Gaglani, Katherine Adams +30 more

Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023

MMWR Morbidity and Mortality Weekly Report(2023)10.15585/mmwr.mm7240a2

N/A

0DataRank · unranked

102 citations

Katharine A. Yuengling, Jennifer DeCuir, Yuwei Zhu, Manjusha Gaglani, Adit A. Ginde +48 more

Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study

Clinical Infectious Diseases(2023)10.1093/cid/ciad031

N/A

0DataRank · unranked

66 citations

Arnold S. Monto, Lois Lamerato, Anurag N. Malani, Adam S. Lauring, H. Keipp Talbot +12 more

Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023

Clinical Infectious Diseases(2023)10.1093/cid/ciad677

N/A

0DataRank · unranked

35 citations

Yuwei Zhu, Ithan D. Peltan, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande +85 more

Influenza Vaccine Effectiveness Among Children: 2011–2020

PEDIATRICS(2023)10.1542/peds.2022-059922

N/A

0DataRank · unranked

26 citations

Brendan Flannery, Manjusha Gaglani, Madhava Beeram, Karen J. Wernli, Michael L. Jackson +10 more

Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network

Clinical Infectious Diseases(2023)10.1093/cid/ciad704

N/A

0DataRank · unranked

25 citations

Zachary A. Weber, Duck‐Hye Yang, Nicola P. Klein, Malini B. DeSilva, Kristin Dascomb +24 more

Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies

Environmental Research(2023)10.1016/j.envres.2023.117297

N/A

0DataRank · unranked

20 citations

Alberto J. Caban‐Martinez, Katherine Ellingson, Shawn C. Beitel, Ashley Fowlkes, Karen Lutrick +24 more

Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022

Clinical Infectious Diseases(2023)10.1093/cid/ciad276

N/A

0DataRank · unranked

33 citations

Katherine Adams, Wesley H. Self, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande +82 more

Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad542

N/A

0DataRank · unranked

26 citations

Zachary A. Weber, Duck‐Hye Yang, Malini B. DeSilva, Kristin Dascomb, Stephanie A. Irving +30 more

Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021–2022 Season, VISION Network

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad015

N/A

0DataRank · unranked

21 citations

Zachary A. Weber, Malini B. DeSilva, Edward Stenehjem, Duck‐Hye Yang, Bruce Fireman +31 more

Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March–November 2020

Emerging infectious diseases(2023)10.3201/eid2902.221014

N/A

0DataRank · unranked

19 citations

Faruque Ahmed, Sara Kim, Karen J. Wernli, Michael L. Jackson, Mary Patricia Nowalk +10 more

Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness

Clinical Infectious Diseases(2023)10.1093/cid/ciad003

N/A

0DataRank · unranked

19 citations

Zachary A. Weber, Katie Allen, Edward Stenehjem, Stephanie A. Irving, Talia L. Spark +37 more

Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network

Influenza and Other Respiratory Viruses(2023)10.1111/irv.13143

N/A

0DataRank · unranked

19 citations

Fagen Xie, Ruchi Yadav, Karen J. Wernli, Emily T. Martin, Edward A. Belongia +7 more

Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2023.100530

N/A

0DataRank · unranked

15 citations

John Riddles, Elizabeth Rowley, Shaun J. Grannis, Manjusha Gaglani, Bruce Fireman +32 more

Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design

Vaccine(2023)10.1016/j.vaccine.2023.11.025

N/A

0DataRank · unranked

12 citations

Allison Avrich Ciesla, Elizabeth Rowley, Zachary A. Weber, Sarah E. Reese, Toan C. Ong +10 more

Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad061

N/A

0DataRank · unranked

8 citations

Christopher Blair, Yuwei Zhu, James D. Chappell, Manjusha Gaglani, Tresa McNeal +37 more

Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022

Emerging infectious diseases(2023)10.3201/eid2912.231070

N/A

0DataRank · unranked

3 citations

Mary Patricia Nowalk, Richard K. Zimmerman, Todd Bear, Carlos G. Grijalva, H. Keipp Talbot +14 more

Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network

medRxiv(2023)10.1101/2023.01.10.23284397

N/A

0DataRank · unranked

6 citations

Fagen Xie, Ruchi Yadav, Karen J. Wernli, Emily T. Martin, Edward A. Belongia +8 more

Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022

medRxiv(2023)10.1101/2023.09.21.23295919

N/A

0DataRank · unranked

1 citations

Ruchi Yadav, Emma K. Noble, Ryan Sandford, Devyani Joshi, Sara Y. Tartof +11 more

Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection

medRxiv(2023)10.1101/2023.03.12.23287173

N/A

0DataRank · unranked

0 citations

Barbra A. Dickerman, Huong Q. Nguyen, Emily T. Martin, Manjusha Gaglani, Karen J. Wernli +6 more

Work Attendance during Acute Respiratory Illness Before and During the COVID-19 Pandemic, United States, 2018–2022

medRxiv(2023)10.1101/2023.08.03.23293611

N/A

0DataRank · unranked

0 citations

Mary Patricia Nowalk, Richard K. Zimmerman, Todd Bear, Carlos G. Grijalva, H. Keipp Talbot +14 more

Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections

medRxiv(2023)10.1101/2023.09.12.23295384

N/A

0DataRank · unranked

0 citations

Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Branden Lau, Jefferey L. Burgess +20 more

Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021—June 2022

medRxiv(2023)10.1101/2023.11.17.23298700

N/A

0DataRank · unranked

0 citations

Ruchi Yadav, Emma K. Noble, Kelsey M. Sumner, Devyani Joshi, Sara Y. Tartof +13 more

Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7308a5

N/A

0DataRank · unranked

77 citations

Amanda B. Payne, Wesley H. Self, Elizabeth Rowley, Kristin Dascomb, Malini B. DeSilva +94 more

Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae584

N/A

0DataRank · unranked

11 citations

Elizabeth Harker, Lauren Grant, Yuwei Zhu, Carlos G. Grijalva, James D. Chappell +88 more

Late‐Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022–April 2023

Influenza and Other Respiratory Viruses(2024)10.1111/irv.13342

N/A

0DataRank · unranked

12 citations

Philip Shirk, Manjusha Gaglani, Manohar B. Mutnal, Mary Patricia Nowalk, Krissy Moehling Geffel +19 more

Effectiveness of Original Monovalent and Bivalent COVID‐19 Vaccines Against COVID‐19‐Associated Hospitalization and Severe In‐Hospital Outcomes Among Adults in the United States, September 2022–August 2023

Influenza and Other Respiratory Viruses(2024)10.1111/irv.70027

N/A

0DataRank · unranked

10 citations

Diya Surie, Yuwei Zhu, Adam S. Lauring, Manjusha Gaglani, Tresa McNeal +48 more

Reduced Effectiveness of Repeat Influenza Vaccination: Distinguishing Among Within-Season Waning, Recent Clinical Infection, and Subclinical Infection

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae220

N/A

0DataRank · unranked

8 citations

Barbra A. Dickerman, Huong Q. Nguyen, Emily T. Martin, Manjusha Gaglani, Karen J. Wernli +22 more

Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses — IVY Network, September 1, 2022–March 30, 2023

Vaccine(2024)10.1016/j.vaccine.2024.126492

N/A

0DataRank · unranked

8 citations

Elizabeth Harker, Aleda M. Leis, Yuwei Zhu, H. Keipp Talbot, Carlos G. Grijalva +43 more

Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months–4 Years, United States, September 2022–April 2023

Journal of the Pediatric Infectious Diseases Society(2024)10.1093/jpids/piae121

N/A

0DataRank · unranked

6 citations

Jasmine Ruffin, Ryan E. Wiegand, Lauren Grant, Tara M Babu, Melissa Briggs‐Hagen +30 more

Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES–RECOVER Prospective Cohort Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae130

N/A

0DataRank · unranked

5 citations

Huashi Li, Melissa M. Coughlin, Jefferson M. Jones, Amadea Britton, Harmony L. Tyner +25 more

Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae090

N/A

0DataRank · unranked

9 citations

Ruchi Yadav, Emma K. Noble, Ryan Sandford, Devyani Joshi, Sara Y. Tartof +12 more

Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness

Scientific Reports(2024)10.1038/s41598-024-72081-z

N/A

0DataRank · unranked

5 citations

Huong Q. Nguyen, Erika Kiniry, C. Hallie Phillips, Manjusha Gaglani, Emily T. Martin +6 more

Molecular features of the serological IgG repertoire elicited by egg-based, cell-based, or recombinant haemagglutinin-based seasonal influenza vaccines: a comparative, prospective, observational cohort study

The Lancet Microbe(2024)10.1016/j.lanmic.2024.06.002

N/A

0DataRank · unranked

4 citations

Foteini Bartzoka, Troy von Beck, Zhu‐Nan Li, Margarita Mishina, Luke S Hebert +29 more

Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022

Influenza and Other Respiratory Viruses(2024)10.1111/irv.13339

N/A

0DataRank · unranked

1 citations

Ruchi Yadav, Emma K. Noble, Kelsey M. Sumner, Devyani Joshi, Sara Y. Tartof +13 more

Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023–24 season

medRxiv(2024)10.1101/2024.10.29.24316377

N/A

0DataRank · unranked

1 citations

Ashley M. Price, Richard K. Zimmerman, Krissy Moehling Geffel, Stacey L. House, Tara Curley +19 more

Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae502

N/A

0DataRank · unranked

0 citations

Yuwei Zhu, Ine Sohn, William B. Stubblefield, Michael B. Streiff, Manjusha Gaglani +89 more

Influenza Vaccine Effectiveness Against Medically Attended Outpatients Illness, United States, 2023–2024 Season

Clinical Infectious Diseases(2025)10.1093/cid/ciae658

N/A

0DataRank · unranked

21 citations

Ashley M. Price, Richard K. Zimmerman, Krissy Moehling Geffel, Stacey L. House, Tara Curley +18 more

Severity of Clinical Presentation and Outcomes in Hospitalized Adult People With Influenza by Type and Subtype, United States—2017–2020

Clinical Infectious Diseases(2025)10.1093/cid/ciaf545

N/A

0DataRank · unranked

4 citations

Nathaniel M. Lewis, H. Keipp Talbot, Yuwei Zhu, Emily T. Martin, Arnold S. Monto +9 more

Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections

Nature Immunology(2025)10.1038/s41590-025-02162-2

N/A

0DataRank · unranked

3 citations

Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Branden Lau, Chieh-Yu Liang +24 more

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Human Vaccines & Immunotherapeutics(2025)10.1080/21645515.2025.2457205

N/A

0DataRank · unranked

1 citations

Mary Patricia Nowalk, Richard K. Zimmerman, Samantha M. Olson, H. Keipp Talbot, Yuwei Zhu +7 more

Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel

Vaccine(2025)10.1016/j.vaccine.2025.127361

N/A

0DataRank · unranked

0 citations

Weiping Cao, Zachary Ende, Suresh S. Sharma, Sean D. Ray, Rashmi Kumari +22 more

Does Home COVID-19 Testing Bias COVID-19 Vaccine Effectiveness Estimates?

American Journal of Preventive Medicine(2025)10.1016/j.amepre.2025.108096

N/A

0DataRank · unranked

0 citations

G.K. Balasubramani, Helen D’Agostino, Richard K. Zimmerman, Arnold S. Monto, Emily T. Martin +12 more

Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States—2019–2020

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1884

N/A

0DataRank · unranked

135 citations

Rebecca Kondor, Jessie R. Chung, Richard K. Zimmerman, Mary Patricia Nowalk, Michael L. Jackson +14 more

Absolute and Relative Effectiveness of Cell Culture–Based and Egg–Based Quadrivalent Inactivated Influenza (Flu) Vaccine Products From the 2014–2015 to 2018–2019 Seasons, US Flu VE Network

Clinical Infectious Diseases(2025)10.1093/cid/ciaf579

N/A

0DataRank · unranked

0 citations

Chandni Raiyani, Kempapura Murthy, Michael Smith, Briget da Graca, Gueorgui Dubrocq +13 more

Effects of Influenza Vaccination in the United States During the 2018–2019 Influenza Season

Clinical Infectious Diseases(2020)10.1093/cid/ciz1244

N/A

0DataRank · unranked

124 citations

Melissa A. Rolfes, Brendan Flannery, Pragati Prasad, Alissa O’Halloran, Shikha Garg +47 more

Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019–2020

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa800

N/A

0DataRank · unranked

45 citations

H. Keipp Talbot, Christopher Trabue, Manjusha Gaglani, Tresa McNeal, Arnold S. Monto +57 more

Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018

Clinical Infectious Diseases(2020)10.1093/cid/ciaa407

N/A

0DataRank · unranked

60 citations

Jessie R. Chung, Emily Smith, H. Keipp Talbot, Christopher Trabue, Richard K. Zimmerman +13 more

Manjusha Gaglani

Indexed papers

Top data-sharing exemplar

Papers